A mouse-adapted SARS-CoV-2 strain replicating in standard laboratory mice

Archive ouverte

Montagutelli, Xavier | Prot, Matthieu | Jouvion, Grégory | Levillayer, Laurine | Conquet, Laurine | Reyes-Gomez, Edouard | Donati, Flora | Albert, Melanie | van der Werf, Sylvie | Jaubert, Jean | Simon-Lorière, Etienne

Edité par CCSD -

Posted July 10, 2021on bioRxiv.. SARS-CoV-2 has infected almost 200 million humans and caused over 4 million deaths worldwide. Evaluating countermeasures and improving our understanding of COVID-19 pathophysiology require access to animal models that replicate the hallmarks of human disease. Mouse infection with SARS-CoV-2 is limited by poor affinity between the virus spike protein and its cellular receptor ACE2. We have developed by serial passages the MACo3 virus strain which efficiently replicates in the lungs of standard mouse strains and induces age-dependent lung lesions. Compared to other mouse-adapted strains and severe mouse models, infection with MACo3 results in mild to moderate disease and will be useful to investigate the role of host genetics and other factors modulating COVID-19 severity.

Suggestions

Du même auteur

Variants with the N501Y mutation extend SARS-CoV-2 host range to mice, with contact transmission

Archive ouverte | Montagutelli, Xavier | CCSD

Receptor recognition is a major determinant of viral host range, infectivity and pathogenesis. Emergences have been associated with serendipitous events of adaptation upon encounters with novel hosts, and the high mutation rate of...

Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2

Archive ouverte | Planchais, Cyril | CCSD

International audience. Antibodies play a pivotal role in protecting from SARS-CoV-2 infection, but their efficacy is challenged by the continuous emergence of viral variants. In this study, we describe two broadly ...

A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters

Archive ouverte | Frantz, Phanramphoei, N. | CCSD

International audience. Several COVID-19 vaccines have now been deployed to tackle the SARS-CoV-2 pandemic, most of them based on messenger RNA or adenovirus vectors.The duration of protection afforded by these vacc...

Chargement des enrichissements...